These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 10565107)

  • 21. [Leucovorin rescue after continuing infusion of high dose methotrexate].
    Yang LH; Lu XT; Gu J; Hua Y; Zhao WH
    Zhonghua Er Ke Za Zhi; 2005 May; 43(5):393-4. PubMed ID: 15924763
    [No Abstract]   [Full Text] [Related]  

  • 22. Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy--a Pediatric Oncology Group study.
    Mahoney DH; Shuster JJ; Nitschke R; Lauer SJ; Steuber CP; Winick N; Camitta B
    J Clin Oncol; 1998 May; 16(5):1712-22. PubMed ID: 9586883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic effect of intrathecal methotrexate during the initial phase of treatment of childhood acute lymphoblastic leukemia. The European Organization for Research and Treatment of Cancer Children's Leukemia Cooperative Group.
    Thyss A; Suciu S; Bertrand Y; Mazingue F; Robert A; Vilmer E; Mechinaud F; Benoit Y; Brock P; Ferster A; Lutz P; Boutard P; Marguerite G; Plouvier E; Michel G; Plantaz D; Munzer M; Rialland X; Chantraine JM; Norton L; Solbu G; Philippe N; Otten J
    J Clin Oncol; 1997 May; 15(5):1824-30. PubMed ID: 9164191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of methotrexate polyglutamates on thioguanine nucleotide concentrations during continuation therapy of acute lymphoblastic leukemia with mercaptopurine.
    Dervieux T; Hancock M; Evans W; Pui CH; Relling MV
    Leukemia; 2002 Feb; 16(2):209-12. PubMed ID: 11840287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Response of children with high-risk acute lymphoblastic leukemia treated with and without cranial irradiation: a report from the Children's Cancer Group.
    Nachman J; Sather HN; Cherlow JM; Sensel MG; Gaynon PS; Lukens JN; Wolff L; Trigg ME
    J Clin Oncol; 1998 Mar; 16(3):920-30. PubMed ID: 9508174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Blood concentration monitoring during high-dose methotrexate treatment].
    Jiao L; Zhou DB; Wang SJ; Zhang W; Duan MH; Li J; Han B; Xu Y; Zhao YQ; Shen T; Wang Q; Ye M
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Oct; 31(5):564-6. PubMed ID: 19968071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Methotrexate-induced interstitial pneumonitis in a child with acute lymphoblastic leukemia].
    Tatsumoto C; Kawakami K; Nagayama J; Kawano H
    Rinsho Ketsueki; 2004 Oct; 45(10):1100-4. PubMed ID: 15553044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient characteristics associated with high-risk methotrexate concentrations and toxicity.
    Relling MV; Fairclough D; Ayers D; Crom WR; Rodman JH; Pui CH; Evans WE
    J Clin Oncol; 1994 Aug; 12(8):1667-72. PubMed ID: 8040679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Random serum methotrexate determinations for assessing compliance with maintenance therapy for childhood acute lymphoblastic leukemia.
    Jaime-Pérez JC; Gómez-Almaguer D; Sandoval-González A; Chapa-Rodríguez A; Gonzàlez-Llano O
    Leuk Lymphoma; 2009 Nov; 50(11):1843-7. PubMed ID: 19860612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma homocysteine, methionine and S-adenosylhomocysteine levels following high-dose methotrexate treatment in pediatric patients with acute lymphoblastic leukemia or Burkitt lymphoma: association with hepatotoxicity.
    Kubota M; Nakata R; Adachi S; Watanabe K; Heike T; Takeshita Y; Shima M
    Leuk Lymphoma; 2014 Jul; 55(7):1591-5. PubMed ID: 24090503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma methotrexate, red blood cell methotrexate, and red blood cell folate values and outcome in children with precursor B-acute lymphoblastic leukemia: a report from the Children's Oncology Group.
    Salzer WL; Winick NJ; Wacker P; Lu X; Devidas M; Shuster JJ; Mahoney DH; Lauer SJ; Camitta BM
    J Pediatr Hematol Oncol; 2012 Jan; 34(1):e1-7. PubMed ID: 21364468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymorphism G80A in the reduced folate carrier gene and its relationship to methotrexate plasma levels and outcome of childhood acute lymphoblastic leukemia.
    Laverdière C; Chiasson S; Costea I; Moghrabi A; Krajinovic M
    Blood; 2002 Nov; 100(10):3832-4. PubMed ID: 12411325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma homocysteine in children with acute lymphoblastic leukemia: changes during a chemotherapeutic regimen including methotrexate.
    Refsum H; Wesenberg F; Ueland PM
    Cancer Res; 1991 Feb; 51(3):828-35. PubMed ID: 1988122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of Biomarkers of Oxidative Stress and Apoptosis in Patients With Severe Methotrexate Neurotoxicity: A Case Series.
    Taylor OA; Hockenberry MJ; McCarthy K; Gundy P; Montgomery D; Ross A; Scheurer ME; Moore IM
    J Pediatr Oncol Nurs; 2015; 32(5):320-5. PubMed ID: 25637187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pharmacokinetics of methotrexate in children with acute lymphoblastic leukemia].
    Lares-Asseff I; Paredes R; Taboada C; Cravioto J; Velázquez M; Roldán RM; Faisal AG
    Bol Med Hosp Infant Mex; 1988 Oct; 45(10):671-80. PubMed ID: 3264171
    [No Abstract]   [Full Text] [Related]  

  • 36. Accumulation of methotrexate and methotrexate polyglutamates in lymphoblasts and treatment outcome in children with B-progenitor-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study.
    Whitehead VM; Shuster JJ; Vuchich MJ; Mahoney DH; Lauer SJ; Payment C; Koch PA; Cooley LD; Look AT; Pullen DJ; Camitta B
    Leukemia; 2005 Apr; 19(4):533-6. PubMed ID: 15716987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk of relapse in childhood acute lymphoblastic leukemia is related to RBC methotrexate and mercaptopurine metabolites during maintenance chemotherapy. Nordic Society for Pediatric Hematology and Oncology.
    Schmiegelow K; Schrøder H; Gustafsson G; Kristinsson J; Glomstein A; Salmi T; Wranne L
    J Clin Oncol; 1995 Feb; 13(2):345-51. PubMed ID: 7531219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intensive intravenous methotrexate and mercaptopurine treatment of higher-risk non-T, non-B acute lymphocytic leukemia: A Pediatric Oncology Group study.
    Camitta B; Mahoney D; Leventhal B; Lauer SJ; Shuster JJ; Adair S; Civin C; Munoz L; Steuber P; Strother D
    J Clin Oncol; 1994 Jul; 12(7):1383-9. PubMed ID: 8021728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Whole brain magnetization transfer histogram analysis of pediatric acute lymphoblastic leukemia patients receiving intrathecal methotrexate therapy.
    Yamamoto A; Miki Y; Adachi S; Kanagaki M; Fushimi Y; Okada T; Kobayashi M; Hiramatsu H; Umeda K; Nakahata T; van Buchem MA; Togashi K
    Eur J Radiol; 2006 Mar; 57(3):423-7. PubMed ID: 16314063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. The Associazione Italiana di Ematologia ed Oncologia Pediatrica.
    Conter V; Aricò M; Valsecchi MG; Rizzari C; Testi AM; Messina C; Mori PG; Miniero R; Colella R; Basso G
    J Clin Oncol; 1995 Oct; 13(10):2497-502. PubMed ID: 7595699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.